SavedAdd your journal

Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 6

The Role of Platelet Count, Platelet Lymphocyte Ratio, and Systemic Immune-Inflammatıon Index in Predicting Lymph Node Metastasis in Colon Cancer

Hakan BÖLÜKBAŞI
Serhan YILMAZ
Mehmet Abdussamet BOZKURT
Engin Okan YILDIRIM
Aziz OCAKOĞLU
Pages
548–553
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Systemic immune-inflammation index, platelet lymphocyte ratio, and platelet count can be used in combination with TNM staging for personalized treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to evaluate the role of platelet counts, platelet lymphocyte ratio, neutrophil lymphocyte ratio, and systemic immune-inflammation index in predicting lymph node metastasis in preoperative period in patients with colon cancer.
📊
Key Findings & Data:Materials and Methods: This study was conducted between May 2015 and May 2020 at the University of Health Sciences, Kanuni Sultan Suleyman Training and Research Hospital.
💡
Conclusion & Impact:Conclusion: Systemic immune-inflammation index, platelet lymphocyte ratio, and platelet count can be used in combination with TNM staging for personalized treatment.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to evaluate the role of platelet counts, platelet lymphocyte ratio, neutrophil lymphocyte ratio, and systemic immune-inflammation index in predicting lymph node metastasis in preoperative period in patients with colon cancer. Materials and Methods: This study was conducted between May 2015 and May 2020 at the University of Health Sciences, Kanuni Sultan Suleyman Training and Research Hospital. A total of 130 patients who underwent colon resection for colon adenocarcinoma were evaluated. They were divided into groups via nodal staging using the TNM classification: N0: 0; N1: 1–3; and N2: 4 or more. Results: A significant difference was observed between the inter-group platelet counts, platelet lymphocyte ratio, and systemic immune-inflammation index. The platelet value was significantly higher in N1 and N2 than in N0. There was also a significant difference between NO and N2 compared with platelet lymphocyte ratio and systemic immune-inflammation index. Conclusion: Systemic immune-inflammation index, platelet lymphocyte ratio, and platelet count can be used in combination with TNM staging for personalized treatment.

🔖

Cite This Article

BÖLÜKBAŞI, H., YILMAZ, S., BOZKURT, M. A., YILDIRIM, E. O., OCAKOĞLU, A. (2022). The Role of Platelet Count, Platelet Lymphocyte Ratio, and Systemic Immune-Inflammatıon Index in Predicting Lymph Node Metastasis in Colon Cancer. Erciyes Medical Journal, Cilt: 43 - Sayı: 6, 548–553. https://ajindex.com/articles/502297

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65(2): 87– 108
  2. Fan XJ, Wan XB, Fu XH, Wu PH, Chen DK, Wang PN, et al. Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer. Tumour Biol 2014; 35(10): 10487–95
  3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144(5): 646–74
  4. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420(6917): 860–7
  5. Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 2009; 249(5): 788–93
  6. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454(7203): 436–44
  7. Halazun KJ, Hardy MA, Rana AA, Woodland DC 4th, Luyten EJ, Mahadev S, et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 2009; 250(1): 141–51
  8. Tazzyman S, Niaz H, Murdoch C. Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth. Semin Cancer Biol 2013; 23(3): 149–58
  9. Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, Ress AL, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 2013; 109(2): 416–21
  10. Levin J, Conley CL. Thrombocytosis associated with malignant disease. Arch Intern Med 1964; 114: 497–500
  11. Placke T, Salih HR, Kopp HG. GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity. J Immunol 2012; 189(1): 154–60 12. Sasaki K, Kawai K, Tsuno NH, Sunami E, Kitayama J. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World J Surg 2012; 36(1): 192–200
  12. Kobayashi N, Usui S, Kikuchi S, Goto Y, Sakai M, Onizuka M, et al. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer 2012; 75(2): 223–7
  13. Passardi A, Scarpi E, Cavanna L, Dall’Agata M, Tassinari D, Leo S, et al. Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer. Oncotarget 2016; 7(22): 33210–9
  14. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al.